Type 1 Diabetes Mellitus Clinical Trials in Chicago, Illinois

4 studies are recruiting for type 1 diabetes mellitus in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

   This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The approximately 393-days study consists of a Screening Period (28 days), Treatment Period (90 days), and Post-Dose Evalua…

   Stage

   Phase 1

   Ages

   12 to 35

   Site

   Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois

   Locations

   45 in total

   Run by

   COUR Pharmaceutical Development Company, Inc.

   See if you can join NCT06783309 on ClinicalTrials.gov

2. A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

   This study is First In Human study for Encapsulated Porcine Islet Cells for Xenotransplantation (OPF-310). The purpose of this study to assess the safety, tolerability, and efficacy of OPF-310 transplantation and to define the recommended Phase 2 dose (RP2D) in adult subjects with unstable Type 1 D…

   Stage

   Phase 1

   Ages

   35 to 70

   Site

   University of Illinois Hospital & Health Sciences System, Chicago, Illinois

   Run by

   Otsuka Pharmaceutical Factory, Inc.

   See if you can join NCT06575426 on ClinicalTrials.gov

3. Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

   This multi-center, randomized, cross-over trial will evaluate the efficacy of the Omnipod 6 System compared with the Omnipod 5 System in individuals with type 1 or type 2 diabetes and suboptimal glycemia.

   Stage

   Not phased

   Ages

   14 to 75

   Site

   Northwestern University, Chicago, Illinois

   Locations

   11 in total

   Run by

   Insulet Corporation

   See if you can join NCT07579702 on ClinicalTrials.gov

4. A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers

   The investigators will assess both effectiveness (primary) and implementation (secondary) outcomes for a distress-reducing intervention, Supporting Teen Problem Solving (STePS). STePS has already undergone an efficacy trial. The current study allows for evaluating the outcomes of STePS by deliverin…

   Stage

   Not phased

   Ages

   14 to 18

   Site

   Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago, Illinois

   Run by

   Jill Weissberg-Benchell, Ph.D.

   See if you can join NCT06709755 on ClinicalTrials.gov